CHAPTER 58
HB 582 - FINAL VERSION
7Apr2021... 0408h
2021 SESSION
21-0772
10/04
HOUSE BILL 582
SPONSORS: Rep. Walz, Merr. 23; Rep. Woods, Merr. 23
COMMITTEE: Health, Human Services and Elderly Affairs
─────────────────────────────────────────────────────────────────
AMENDED ANALYSIS
This bill allows for certain prescriptions for treatment of attention deficit disorder, attention deficit disorder with hyperactivity, or narcolepsy to be for 90 days.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
7Apr2021... 0408h 21-0772
10/04
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty One
AN ACT relative to prescriptions for the treatment of attention deficit disorder, attention deficit disorder with hyperactivity, or narcolepsy.
Be it Enacted by the Senate and House of Representatives in General Court convened:
58:1 Controlled Drug Act; Sale by Pharmacists; Attention Deficit Disorder, Attention Deficit Disorder with Hyperactivity, Narcolepsy; Prescriptions. Amend RSA 318-B:9, IV to read as follows:
IV. No prescription shall be filled for more than a 34-day supply upon any single filling for controlled drugs of schedules II or III; provided, however, that for controlled drugs, in schedules II or III, that are commercially packaged for dispensing directly to the patient, such as metered sprays and inhalers, liquids packaged in bottles with calibrated droppers, and certain topical preparations packaged with metered dispensing pumps may be filled for greater than a 34-day supply, but not more than 60 days, utilizing the smallest available product size, in order to maintain the dosing integrity of the commercially packaged containers; and, provided that with regard to amphetamines and methylphenidate hydrochloride, a prescription may be filled for up to a [60-day] 90-day supply if either such prescription specifies it is being used for the treatment of attention deficit disorder, attention deficit disorder with hyperactivity, or narcolepsy.
58:2 Effective Date. This act shall take effect 60 days after its passage.
Approved: May 25, 2021
Effective Date: July 24, 2021
Date | Body | Type |
---|---|---|
Feb. 16, 2021 | House | Hearing |
House | Floor Vote | |
April 14, 2021 | Senate | Hearing |
April 29, 2021 | Senate | Floor Vote |
April 14, 2021 | Senate | Hearing |
April 29, 2021 | Senate | Floor Vote |
May 25, 2021: Signed by Governor Sununu 05/25/2021; Chapter 58; Eff: 07/24/2021
May 27, 2021: Signed by Governor Sununu 05/25/2021; Chapter 58; Eff: 07/24/2021
May 17, 2021: Enrolled (in recess of) 04/09/2021 HJ 7 P. 104
April 9, 2021: Enrolled (in recess of) 04/09/2021 HJ 7 P. 104
May 13, 2021: Enrolled Adopted, VV, (In recess 05/13/2021); SJ 16
May 17, 2021: Enrolled Adopted, VV, (In recess 05/13/2021); SJ 16
April 29, 2021: Ought to Pass: RC 24Y-0N, MA; OT3rdg; 04/29/2021; SJ 13
April 29, 2021: Ought to Pass: RC 24Y-0N, MA; OT3rdg; 04/29/2021; SJ 13
April 29, 2021: Committee Report: Ought to Pass, 04/29/2021; Vote 5-0; CC; SC 21
April 22, 2021: Committee Report: Ought to Pass, 04/29/2021; Vote 5-0; CC; SC 21
April 14, 2021: Remote Hearing: 04/14/2021, 09:15 am; Links to join the hearing can be found in the Senate Calendar; SC 19
April 8, 2021: Remote Hearing: 04/14/2021, 09:15 am; Links to join the hearing can be found in the Senate Calendar; SC 19
April 1, 2021: Introduced 04/01/2021 and Referred to Health and Human Services; SJ 11
April 7, 2021: Introduced 04/01/2021 and Referred to Health and Human Services; SJ 11
April 7, 2021: Reconsider (Rep. Osborne): MF VV 04/07/2021 HJ 5 P. 50
April 7, 2021: Reconsider (Rep. Osborne): MF VV 04/07/2021 HJ 5 P. 50
April 7, 2021: Ought to Pass with Amendment 2021-0408h: MA VV 04/07/2021 HJ 5 P. 36
April 7, 2021: Ought to Pass with Amendment 2021-0408h: MA VV 04/07/2021 HJ 5 P. 36
April 7, 2021: Amendment # 2021-0408h: AA VV 04/07/2021 HJ 5 P. 36
April 7, 2021: Amendment # 2021-0408h: AA VV 04/07/2021 HJ 5 P. 36
March 2, 2021: Committee Report: Ought to Pass with Amendment # 2021-0408h (Vote 20-0; CC) HC 18 P. 16
: Committee Report: Ought to Pass with Amendment # 2021-0408h (Vote 20-0; CC) HC 18 P. 16
Feb. 16, 2021: Public Hearing: 02/16/2021 09:00 am Members of the public may attend using the following link: To join the webinar: https://www.zoom.us/j/94563888809 / Executive session on pending legislation may be held throughout the day (time permitting) from the time the committee is initially convened.
Jan. 12, 2021: Introduced (in recess of) 01/06/2021 and referred to Health, Human Services and Elderly Affairs HJ 2 P. 54
Jan. 6, 2021: Introduced (in recess of) 01/06/2021 and referred to Health, Human Services and Elderly Affairs HJ 2 P. 54